Status:
COMPLETED
Effects of Parenteral Nutrition in HSCT
Lead Sponsor:
St. Petersburg State Pavlov Medical University
Conditions:
Hematologic Malignancy
Eligibility:
All Genders
2+ years
Phase:
NA
Brief Summary
Nutritional therapy implementation in hematopoietic stem cell transplantation (HSCT) have undergone changes recently due to new conditioning regimen and graft versus disease prophylaxis, novel enteral...
Detailed Description
The study is interventional: in children and adolescents (2-17 years), adults with blood malignancy and inherited diseases who underwent autologous or allogeneic HSCT, nutritional status, parenteral n...
Eligibility Criteria
Inclusion
- Autologous HSCT
- Allogeneic HSCT
- Patients with indications for parenteral nutrition defined as unable to eat more than 50% of oral food intake due to posttransplant complications which leads to malnutrition and malabsorption
- Signed informed consent
- Age \> 2 years
Exclusion
- \- Secondary HSCT
Key Trial Info
Start Date :
February 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2021
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT04425642
Start Date
February 1 2020
End Date
June 1 2021
Last Update
June 24 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pavlov First Saint-Petersburg State Medical University
Saint Petersburg, Russia, 197022